Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May

Estimated SARS-CoV-2 Seroprevalence Among Persons Aged <18 Years — Mississippi, May–September 2020

Published:2021-03-05 Issue:9 Volume:70 Page:312-315
ISSN:0149-2195
Container-title:MMWR. Morbidity and Mortality Weekly Report
language:
Short-container-title:MMWR Morb. Mortal. Wkly. Rep.

Author:

Hobbs Charlotte V.,Drobeniuc Jan,Kittle Theresa,Williams John,Byers Paul,Satheshkumar Panayampalli S.,Inagaki Kengo,Stephenson Meagan,Kim Sara S.,Patel Manish M.,Flannery Brendan,Alston Bailey,Bolcen Shanna J.,Boulay Darbi,Browning Peter,Cronin Li,David Ebenezer,Hayden Tonya,Li Han,Lim Travis,Maniatis Panagiotis,Patel Palak,Pauly Mathew,Poe Amanda,Punkova Lili,Semenova Vera,Steward-Clark Evelene P.,Tejada Alexandra,Zellner Briana, ,

Publisher

Centers for Disease Control MMWR Office

Subject

Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology

Reference9 articles.

1. Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak.;Dingens;Nat Commun,2020

2. Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, 2020.;Havers;JAMA Intern Med,2020

3. Bajema KL, Wiegand RE, Cuffe K, Estimated SARS-CoV-2 seroprevalence in the US as of September 2020. JAMA Intern Med 2020. Epub November 24, 2020. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2773576

4. Interpreting diagnostic tests for SARS-CoV-2.;Sethuraman;JAMA,2020

5. SARS-CoV-2 positivity rates among children of racial and ethnic minority groups in Mississippi.;Inagaki;Pediatrics,2021

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Features of gender, age, social factors and polymorbidity in patients, undergone COVID-19;Сибирский научный медицинский журнал;2024-08-30

2. Risk of COVID-19 in Children throughout the Pandemic and the Role of Vaccination: A Narrative Review;Vaccines;2024-08-29

3. Seroprevalence of SARS‐CoV‐2 in pediatric hematology‐oncology patients;Pediatric Blood & Cancer;2024-07-22

4. Combination of rRT-PCR and Clinical Features to Predict Coronavirus Disease 2019 for Nosocomial Infection Control;Infection and Drug Resistance;2024-01

5. Pediatric diabetes mellitus hospitalizations and COVID-19 pandemic response measures;Diabetes Research and Clinical Practice;2024-01